UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030136
Receipt number R000034411
Scientific Title In vitro neuraminidase inhibitory concentration of four neuraminidase inhibitors and their clinical efficacy
Date of disclosure of the study information 2017/11/28
Last modified on 2018/08/23 15:34:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

In vitro neuraminidase inhibitory concentration of four neuraminidase inhibitors and their clinical efficacy

Acronym

Survey for virus resistance and clinical efficacy of four NA inhibitors

Scientific Title

In vitro neuraminidase inhibitory concentration of four neuraminidase inhibitors and their clinical efficacy

Scientific Title:Acronym

Survey for virus resistance and clinical efficacy of four NA inhibitors

Region

Japan


Condition

Condition

Influenza

Classification by specialty

Medicine in general Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

IC50 of influenza virus and clinical efficacy

Basic objectives2

Others

Basic objectives -Others

IC50
Duration of fever

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

IC50
Duration of fever

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Influenza diagnosed with an influenza antigen detection kit

Key exclusion criteria

N/A

Target sample size

240


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Kawai

Organization

Kawai Clinic

Division name

Medicine in general

Zip code


Address

4-32 Kanazono-cho Gifu-shi, Gifu, 500-8113

TEL

058-245-0564

Email

nkawai@city.gifu.med.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chigusa Iwasaki

Organization

RICERCA CLINICA Co.,Ltd

Division name

Clinical support center

Zip code


Address

2-18-30 Yaesuhakata Bld.6F, Hakataeki Higashi, Hakata-ku, Fukuoka-shi, Fukuoka 812-0013

TEL

092-435-1150

Homepage URL


Email

secretary@ricercaclinica.jp


Sponsor or person

Institute

Japan Physicians Association

Institute

Department

Personal name



Funding Source

Organization

DAIICHI SANKYO COMPANY, LIMITED

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 05 Day

Date of IRB


Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry

2018 Year 07 Month 30 Day

Date trial data considered complete

2018 Year 08 Month 10 Day

Date analysis concluded



Other

Other related information

IC50
Duration of fever


Management information

Registered date

2017 Year 11 Month 27 Day

Last modified on

2018 Year 08 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034411


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name